Two drugs from Pfizer Inc and Eli Lilly  Co that employ a new therapeutic approach showed promise in slowing the course of breast cancer according to earlystage research released on Sunday The drug from Pfizer taken in a patient study together with a therapy currently available stopped tumors from growing for a median of more than  monthsabout twice as long as the current treatment alone researchers said Meantime Lillys drug showed antitumor activity in  of  patients